Goldman Sachs
ZBH icon

Goldman Sachs’s Zimmer Biomet ZBH Stock Holding History

Goldman Sachs’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,000
Closed -$2.62M – 5898
2023
Q2 		$2.62M Buy
+18,000
New +$2.45M ﹤0.01% 3660
2022
Q1 		– Sell
-10,609
Closed -$1.31M – 6950
2021
Q4 		$1.31M Buy
+10,609
New +$1.39M ﹤0.01% 4619
2020
Q4 		– Sell
-18,540
Closed -$2.45M – 5741
2020
Q3 		$2.45M Buy
18,540
+14,008
+309% +$1.83M ﹤0.01% 3429
2020
Q2 		$525K Sell
4,532
-42,848
-90% -$4.94M ﹤0.01% 4354
2020
Q1 		$4.65M Buy
47,380
+38,728
+448% +$5.08M ﹤0.01% 2706
2019
Q4 		$1.26M Buy
+8,652
New +$1.19M ﹤0.01% 3973
2019
Q1 		– Sell
-51,500
Closed -$5.19M – 5504
2018
Q4 		$5.19M Buy
+51,500
New +$5.79M ﹤0.01% 2847
2017
Q2 		– Sell
-33,063
Closed -$3.92M – 7010
2017
Q1 		$3.92M Buy
33,063
+32,754
+10,600% +$3.71M ﹤0.01% 3145
2016
Q4 		$31K Buy
+309
New +$33.1K ﹤0.01% 6529
2016
Q3 		– Sell
-1,957
Closed -$229K – 7219
2016
Q2 		$229K Buy
+1,957
New +$221K ﹤0.01% 5589
2014
Q3 		– Sell
-5,562
Closed -$561K – 7286
2014
Q2 		$561K Sell
5,562
-85,799
-94% -$8.37M ﹤0.01% 5206
2014
Q1 		$8.39M Sell
91,361
-166,963
-65% -$15.4M ﹤0.01% 2523
2013
Q4 		$23.4M Buy
258,324
+208,472
+418% +$18M 0.01% 1619
2013
Q3 		$3.98M Sell
49,852
-84,254
-63% -$6.63M ﹤0.01% 3184
2013
Q2 		$9.76M Buy
+134,106
New +$10M ﹤0.01% 2117

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's ZBH Position: Q1 2026 in Review

Goldman Sachs increased its Zimmer Biomet (ZBH) stake by 6.9% in Q1 2026, buying an estimated $6.4M and bringing the position to 1,088,213 shares worth $98.4M. The position accounts for 0.01% of the portfolio, ranked #1042.

Goldman Sachs first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.52B in Q2 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Goldman Sachs held 1,088,213 shares of Zimmer Biomet worth $98.4M as of Q1 2026.
  • Goldman Sachs bought 69,794 Zimmer Biomet shares in Q1 2026, an estimated $6.4M.
  • Zimmer Biomet made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1042 holding.
  • Goldman Sachs first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Zimmer Biomet position peaked at $3.52B in Q2 2015.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.